Neuronetics (Nasdaq:STIM) announced today that it entered into a commercial partnership with Alleviant Health Centers. Under the agreement, Malvern, Pennsylvania-based Neuronetics will be the exclusive supplier of new transcranial magnetic stimulation (TMS) equipment to Alleviant and its clinics. According to a news release, an initial six NeuroStar advanced therapy systems — Neuronetics’ non-drug, non-invasive treatment […]
alleviantmedical
Alleviant Medical completes $6.5m offering
Congestive heart failure treatment developer Alleviant Medical filed an SEC Form D to confirm the sale of $6.5 million in an equity offering. The Austin, Texas-based company reached its total offering amount of $6.5 million after making the first sale in the new notice on May 1. It had no intention of letting the offering […]
Congestive heart failure device dev Alleviant Medical raises $1m
Alleviant Medical has raised $1.1 million in a new round of debt and options financing, according to an SEC filing posted this week. Money in the round came from 15 unnamed sources, according to the SEC filing, with the first sale recorded on December 19 last year. The company has closed the round early, and is […]
